Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Nel ASA Faces Severe Headwinds as Order Intake Plummets

Robert Sasse by Robert Sasse
October 21, 2025
in Analysis, Earnings, European Markets, Hydrogen, Turnaround
0
Nel ASA Stock
0
SHARES
24
VIEWS
Share on FacebookShare on Twitter

The hydrogen sector specialist Nel ASA is confronting substantial operational challenges, with recent quarterly results revealing significant deterioration across key performance metrics. The company’s latest financial disclosures paint a concerning picture for the electrolyzer manufacturer’s near-term prospects.

Financial Performance Shows Marked Decline

During the second quarter of 2025, Nel ASA reported revenues of just 174 million Norwegian Kronen, representing a stark 48 percent decline compared to the same period last year. The company’s operational losses widened slightly, with EBITDA standing at negative 86 million NOK. These figures underscore the substantial operational headwinds the company currently faces, highlighting the gap between the renewable energy sector’s long-term potential and immediate implementation challenges.

Order Collapse Reaches Critical Levels

The most alarming development emerges from the company’s order pipeline. New order intake collapsed by 74 percent year-over-year to a mere 71 million Norwegian Kronen. The order backlog, a crucial indicator of future revenue potential, contracted significantly by 40 percent to 1,249 million Kronen.

This downturn was particularly severe within the alkaline electrolyzer segment, where orders plummeted by 94 percent. While the PEM segment demonstrated relative stability, it proved insufficient to counterbalance the overwhelming decline across the business. This pattern suggests deep-seated market uncertainty and hesitation among potential clients.

Should investors sell immediately? Or is it worth buying Nel ASA?

Industry-Wide Pressures Intensify

Nel ASA’s struggles occur against a backdrop of sector-wide difficulties. The entire hydrogen industry is experiencing protracted delays in final investment decisions for major projects. This widespread investment caution represents a primary driver behind the deteriorating order figures.

The company suffered an additional setback with energy firm Statkraft canceling a significant 40-megawatt electrolyzer contract. Market conditions currently present little room for optimistic interpretation, as demonstrated by these key metrics:

  • Q2 2025 Revenue: 48% year-over-year decrease
  • Q2 2025 Order Intake: 74% year-over-year decline
  • Order Backlog: 40% year-over-year reduction
  • Q2 2025 EBITDA: Negative 86 million NOK

Despite these challenging conditions, a recent order from H2 Energy in early October provided a minor positive development. However, this single contract does little to alter the prevailing negative trajectory. The company’s performance continues to reflect a clear downward trend, with recovery prospects remaining uncertain amid current market dynamics.

Ad

Nel ASA Stock: Buy or Sell?! New Nel ASA Analysis from March 25 delivers the answer:

The latest Nel ASA figures speak for themselves: Urgent action needed for Nel ASA investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

Nel ASA: Buy or sell? Read more here...

Tags: Nel ASA
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Corning Stock
AI & Quantum Computing

Corning’s Strategic Alliance with Meta Fuels Investor Confidence

March 25, 2026
Gossamer Bio Stock
Analysis

Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026

March 25, 2026
Fair Isaac Stock
Analysis

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

March 25, 2026
Next Post
Vulcan Energy Resources Stock

Strategic Partnership with Glencore Marks Turning Point for Vulcan Energy

Infineon Stock

Infineon Shares: The Struggle for Market Momentum

Commerzbank Stock

Commerzbank Unleashes Billion-Euro Share Buyback Program

Recommended

Finance_ People trading stocks

Analyst Upgrades QuinStreet Stock to Strong Buy with Increased Price Target

2 years ago
Trimble Stock

Trimble Stock: A Study in Contrasting Signals

7 months ago
Regency Centers Stock

Regency Centers Stock: Strong Dividend Hike Meets Market Skepticism

5 months ago
Cardinal Health Stock

Cardinal Health Shares Test Key Support Level Amid Sector Uncertainty

6 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026

Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

Figma Embraces Third-Party AI to Power Its Design Ecosystem

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

Trending

Coherent Stock
AI & Quantum Computing

Coherent Stock Accelerates Toward New Highs on Key Breakthroughs

by Kennethcix
March 25, 2026
0

Shares of Coherent surged this week, propelled by a landmark technological demonstration and significant corporate developments that...

Corning Stock

Corning’s Strategic Alliance with Meta Fuels Investor Confidence

March 25, 2026
Dell Stock

Dell’s Quantum Security Push Amidst AI-Driven Growth

March 25, 2026
Gossamer Bio Stock

Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026

March 25, 2026
SOXX ETF Stock

Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Coherent Stock Accelerates Toward New Highs on Key Breakthroughs
  • Corning’s Strategic Alliance with Meta Fuels Investor Confidence
  • Dell’s Quantum Security Push Amidst AI-Driven Growth

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com